Nonetheless, our findings highlight that manipulation of SMAD2 expression can be a promising therapeutic approach against PD, since knockdown of SMAD2 showed pronounced protective efficacy consistently across all three readout methods. This evidence concerns the gene SMAD2 and Parkinson disease.